Company News
Biocon Malaysia Receives EMA Insulin Fill Finish Approval
Biocon Ltd received EMA approval for a new insulin fill finish line at its Malaysia facility.
The approval covers Semglee® (insulin glargine) production for the European market.
Supplies to Europe fro
